Somber
发表于 2025-3-28 15:24:34
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/i/image/462297.jpg
employor
发表于 2025-3-28 22:04:08
https://doi.org/10.1007/978-3-030-79308-1biomarkers; immune checkpoint inhibitors; resistance to therapy; immune-related adverse events; patient-
Dealing
发表于 2025-3-28 23:37:53
Landscape of Immunotherapy in Genitourinary Malignancies, development to predict response to immunotherapy and risk of toxicity. This book chapter is a comprehensive review of immunotherapeutic approaches, both approved and investigational, for the treatment of renal cell carcinoma, urothelial carcinoma, and prostate cancer.
Maximize
发表于 2025-3-29 05:54:20
http://reply.papertrans.cn/47/4623/462297/462297_44.png
mortuary
发表于 2025-3-29 09:32:12
http://reply.papertrans.cn/47/4623/462297/462297_45.png
Infect
发表于 2025-3-29 12:27:23
http://reply.papertrans.cn/47/4623/462297/462297_46.png
官僚统治
发表于 2025-3-29 18:50:18
CAR T Cells, this field involve “taking the breaks off” and “pushing the pedal” of the immune system. These therapies, namely, immune checkpoint inhibitors and adoptive cell therapy, respectively, have been successful in a variety of malignancies, while the former mostly in solid tumors and the latter in hemato
CRP743
发表于 2025-3-29 20:48:13
Hepatobiliary and Pancreatic Adverse Events,nts may present with jaundice, fever, or malaise. Rarely, it may cause liver failure and death. The diagnosis of IMH is made after careful exclusion of other causes of acute hepatitis based on medical history, laboratory evaluation, imaging, and liver histological findings. In clinically significant
Virtues
发表于 2025-3-30 02:10:52
http://reply.papertrans.cn/47/4623/462297/462297_49.png
FELON
发表于 2025-3-30 06:48:02
http://reply.papertrans.cn/47/4623/462297/462297_50.png